Teladoc Health Inc (TDOC) concluded trading on Tuesday at a closing price of $9.09, with 3.66 million shares of worth about $33.29 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.30% during that period and on December 31, 2024 the price saw a loss of about -2.36%. Currently the company’s common shares owned by public are about 171.94M shares, out of which, 168.52M shares are available for trading.
Stock saw a price change of -0.33% in past 5 days and over the past one month there was a price change of -24.12%. Year-to-date (YTD), TDOC shares are showing a performance of -57.82% which decreased to -57.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.76 but also hit the highest price of $22.54 during that period. The average intraday trading volume for Teladoc Health Inc shares is 5.29 million. The stock is currently trading -9.39% below its 20-day simple moving average (SMA20), while that difference is down -7.19% for SMA50 and it goes to -11.42% lower than SMA200.
Teladoc Health Inc (NYSE: TDOC) currently have 171.94M outstanding shares and institutions hold larger chunk of about 73.69% of that.
The stock has a current market capitalization of $1.53B and its 3Y-monthly beta is at 1.01. It has posted earnings per share of -$5.78 in the same period. It has Quick Ratio of 1.65 while making debt-to-equity ratio of 1.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TDOC, volatility over the week remained 4.59% while standing at 5.88% over the month.
Stock’s fiscal year EPS is expected to drop by -333.92% while it is estimated to increase by 84.92% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on November 15, 2024 offering a Buy rating for the stock and assigned a target price of $14 to it. Coverage by Jefferies stated Teladoc Health Inc (TDOC) stock as a Hold in their note to investors on September 17, 2024, suggesting a price target of $10 for the stock. On February 29, 2024, Cantor Fitzgerald Initiated their recommendations, while on February 26, 2024, Leerink Partners Initiated their ratings for the stock with a price target of $17. Stock get a Neutral rating from DA Davidson on January 17, 2024.
